Nurix Therapeutics, Inc. (26) | Change of Control Agreements (2)
- Executive Severance and Change in Control Plan, as amended and restated on January 19, 2022, and form of Participation Agreement thereunder (Filed With SEC on January 28, 2022)
- Form of Severance and Change in Control Agreement (Filed With SEC on July 20, 2020)
